Your browser doesn't support javascript.
loading
miR-4432 Targets FGFBP1 in Human Endothelial Cells.
Avvisato, Roberta; Mone, Pasquale; Jankauskas, Stanislovas S; Varzideh, Fahimeh; Kansakar, Urna; Gambardella, Jessica; De Luca, Antonio; Matarese, Alessandro; Santulli, Gaetano.
Affiliation
  • Avvisato R; Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Mone P; Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Jankauskas SS; Department of Advanced Biomedical Sciences, "Federico II" University, 80131 Naples, Italy.
  • Varzideh F; Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Kansakar U; Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Gambardella J; Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • De Luca A; Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Matarese A; Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA.
  • Santulli G; Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY 10461, USA.
Biology (Basel) ; 12(3)2023 Mar 16.
Article in En | MEDLINE | ID: mdl-36979151
ABSTRACT
MicroRNAs (miRs) are small non-coding RNAs that modulate the expression of several target genes. Fibroblast growth factor binding protein 1 (FGFBP1) has been associated with endothelial dysfunction at the level of the blood-brain barrier (BBB). However, the underlying mechanisms are mostly unknown and there are no studies investigating the relationship between miRs and FGFBP1. Thus, the overarching aim of the present study was to identify and validate which miR can specifically target FGFBP1 in human brain microvascular endothelial cells, which represent the best in vitro model of the BBB. We were able to identify and validate miR-4432 as a fundamental modulator of FGFBP1 and we demonstrated that miR-4432 significantly reduces mitochondrial oxidative stress, a well-established pathophysiological hallmark of hypertension.
Key words

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biology (Basel) Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biology (Basel) Year: 2023 Type: Article Affiliation country: United States